多谢分享 确实有标题党之嫌但是文章里的一段话还是让我觉得有点惊讶的,sinovac给新加坡政府的数据还是不足 这都一年了
Sinovac remains unregistered and is not authorised by the Health Sciences Authority (HSA), and is to be provided only under the SAR framework. As such, it will not be covered under the Vaccine Injury Financial Assistance Programme (VIFAP) meant for the national vaccination programme.
Prof Mak noted that there still is some "outstanding data" on the vaccine that Sinovac has not provided to HSA, which is required to give "complete assurance" about its quality and safety profile. "We look forward, if data becomes available for us, then to (commence) this process of evaluation but unfortunately we're not able to do so."
是有严重问题还是数据没给足
这是两个攻击点。你可以再开一贴质疑,而不是博眼球失败迅速拉个垫背的理由。